“CRISPR-Cas9 Gene Editing for Targeting Cancer Stem Cells in Glioblastoma Multiforme”, IJBR, vol. 3, no. 2, pp. 394–407, Feb. 2025, doi: 10.70749/ijbr.v3i2.712.